Provided is the use of a muramyl dipeptide (MDP)/DNA-microparticle for the manufacture of a medicament for the prophylactic or therapeutic treatment of an infection caused by a virus and/or a bacterium in a subject in need thereof. The medicament can induce a Th1-type immune response and the infection to be treated can be influenza, plague or tuberculosis.